Literature DB >> 16242759

The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer.

Patricia A Parker1, Andrzej Kudelka, Karen Basen-Engquist, John Kavanagh, Janet de Moor, Lorenzo Cohen.   

Abstract

OBJECTIVE: The goal of the current study was to determine how much women with ovarian cancer know about their cancer and CA125 testing and how much women focus on or are preoccupied with their CA125 levels. We also examined the direct and moderating effects of knowledge and CA125 preoccupation on two measures of distress (depressive symptoms and anxiety).
METHODS: Participants were 126 women with epithelial ovarian cancer. Patients completed questionnaires of knowledge, CA125 preoccupation, and distress at the beginning of the first or a new round of chemotherapy.
RESULTS: Both knowledge and preoccupation with CA125 levels were associated with depressive and anxiety symptoms. More importantly, knowledge appeared to moderate the association between CA125 preoccupation and depressive symptoms. That is, for patients with lower levels of knowledge, more CA125 preoccupation was associated with more depressive symptoms. However, there was no such association in women with higher levels of knowledge.
CONCLUSION: Our results suggest that it may be possible to decrease depressive symptoms in women who are overly preoccupied or worried about their CA125 levels by improving their knowledge of aspects of their disease and the surveillance process.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242759     DOI: 10.1016/j.ygyno.2005.08.057

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  15 in total

Review 1.  A systematic review of ovarian cancer and fear of recurrence.

Authors:  Melissa Ozga; Carol Aghajanian; Shannon Myers-Virtue; Glynnis McDonnell; Sabrina Jhanwar; Shira Hichenberg; Isabel Sulimanoff
Journal:  Palliat Support Care       Date:  2015-03-02

2.  Use and Costs of Disease Monitoring in Women With Metastatic Breast Cancer.

Authors:  Melissa K Accordino; Jason D Wright; Sowmya Vasan; Alfred I Neugut; Grace C Hillyer; Jim C Hu; Dawn L Hershman
Journal:  J Clin Oncol       Date:  2016-05-09       Impact factor: 44.544

Review 3.  Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment.

Authors:  Fiona Kew; Khadra Galaal; Andrew Bryant; Raj Naik
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

Review 4.  Ovarian cancer: the duplicity of CA125 measurement.

Authors:  Amer K Karam; Beth Y Karlan
Journal:  Nat Rev Clin Oncol       Date:  2010-04-06       Impact factor: 66.675

5.  CA 125 and the detection of recurrent ovarian cancer: a reasonably accurate biomarker for a difficult disease.

Authors:  Robert C Bast
Journal:  Cancer       Date:  2010-06-15       Impact factor: 6.860

6.  Holding back sharing concerns, dispositional emotional expressivity, perceived unsupportive responses and distress among women newly diagnosed with gynecological cancers.

Authors:  Sharon Manne; Shannon Myers; Melissa Ozga; David Kissane; Debby Kashy; Stephen Rubin; Carolyn Heckman; Norm Rosenblum
Journal:  Gen Hosp Psychiatry       Date:  2013-10-09       Impact factor: 3.238

7.  Quality of life among women after surgery for ovarian cancer.

Authors:  Dena Schulman-Green; Elizabeth Ercolano; Michael Dowd; Peter Schwartz; Ruth McCorkle
Journal:  Palliat Support Care       Date:  2008-09

Review 8.  Issues of ovarian cancer survivors in the USA: a literature review.

Authors:  Katrina F Trivers; Jennifer Rees Patterson; Katherine B Roland; Juan L Rodriguez
Journal:  Support Care Cancer       Date:  2013-07-12       Impact factor: 3.603

9.  Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.

Authors:  Daphne L Wang; Kelly B Smith; Sonia Esparza; Fawn A Leigh; Alona Muzikansky; Elyse R Park; Scott R Plotkin
Journal:  Genet Med       Date:  2012-08-09       Impact factor: 8.822

10.  Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer.

Authors:  Katharine M Esselen; Angel M Cronin; Kristin Bixel; Michael A Bookman; Robert A Burger; David E Cohn; Mihaela Cristea; Jennifer J Griggs; Charles F Levenback; Gina Mantia-Smaldone; Larissa A Meyer; Ursula A Matulonis; Joyce C Niland; Charlotte Sun; David M O'Malley; Alexi A Wright
Journal:  JAMA Oncol       Date:  2016-11-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.